EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study

Kapil Gururangan, Veronica J Peschansky, Grace Van Hyfte, Parul Agarwal, Leah J Blank, Brian Mathew, Jonathan Goldstein, Churl-Su Kwon, Louise McCarthy, Ariella Cohen, Andy Ho Wing Chan, Pojen Deng und 22 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12370-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurology, 2024. Verfasst von Kapil Gururangan und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: COVID-19, Hospital Mortality. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To describe the frequency of neuropsychiatric complications among hospitalized patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing comorbidities and clinical outcomes. METHODS: We retrospectively identified all patients hospitalized with COVID-19 within a large multicenter New York City health system between March 15, 2020 and May 17, 2021 and randomly selected a representative cohort for detailed chart review. Clinical data, including the occurrence of neuropsychiatric complications (categorized as either altered mental status [AMS] or other neuropsychiatric complications) and in-hospital mortality, were extracted using an electronic medical record database and individual chart review. Associations between neuropsychiatric complications, comorbidities, laboratory findings, and in-hospital mortality were assessed using multivariate logistic regression. RESULTS: Our study cohort consisted of 974 patients, the majority were admitted during the first wave of the pandemic. Patients were treated with anticoagulation (88.4%), glucocorticoids (24.8%), and remdesivir (10.5%); 18.6% experienced severe COVID-19 pneumonia (evidenced by ventilator requirement). Neuropsychiatric complications occurred in 58.8% of patients; 39.8% experienced AMS; and 19.0% experienced at least one other complication (seizures in 1.4%, ischemic stroke in 1.6%, hemorrhagic stroke in 1.0%) or symptom (headache in 11.4%, anxiety in 6.8%, ataxia in 6.3%). Higher odds of mortality, which occurred in 22.0%, were associated with AMS, ventilator support, increasing age, and higher serum inflammatory marker levels. Anticoagulant therapy was associated with lower odds of mortality and AMS. CONCLUSION: Neuropsychiatric complications of COVID-19, especially AMS, were common, varied, and associated with in-hospital mortality in a diverse multicenter cohort at an epicenter of the COVID-19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hospital MortalityHumansMaleFemaleMiddle AgedAgedRetrospective StudiesNew York CityCohort StudiesAdultComorbidityMental DisordersAged, 80 and overSARS-CoV-2

Stichwörter der Autor:innen

Coronavirus disease 2019Mount Sinai Health SystemNeuroCOVIDNeurological complicationsSARS-CoV-2

Autor:innen und Institutionen

  • Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Department of Population Health Science and Policy, Institute of Health Care Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Departments of Neurosurgery, Neurology, Epidemiology, and the Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
  • Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.

Förderung

  • NIH HHS

Zitieren

APA

Gururangan, K., Peschansky, V. J., Van Hyfte, G., Agarwal, P., Blank, L. J., Mathew, B., Goldstein, J., Kwon, C. S., McCarthy, L., Cohen, A., Chan, A. H. W., Deng, P., Dhamoon, M., Gutzwiller, E., Hao, Q., He, C., Klenofsky, B., Lemus, H. N., Marcuse, L., …, & Sinai NeuroCOVID-19 Study Group (2024). Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study. Journal of Neurology. https://doi.org/10.1007/s00415-024-12370-9

Vancouver

Gururangan K, Peschansky VJ, Van Hyfte G, Agarwal P, Blank LJ, Mathew B, et al. Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study. Journal of Neurology. 2024. doi:10.1007/s00415-024-12370-9

BibTeX
@article{Gururangan2024,
  author = {Gururangan, Kapil and Peschansky, Veronica J and Van Hyfte, Grace and Agarwal, Parul and Blank, Leah J and Mathew, Brian and Goldstein, Jonathan and Kwon, Churl-Su and McCarthy, Louise and Cohen, Ariella and Chan, Andy Ho Wing and Deng, Pojen and Dhamoon, Mandip and Gutzwiller, Eveline and Hao, Qing and He, Celestine and Klenofsky, Britany and Lemus, Hernan Nicolas and Marcuse, Lara and Navis, Allison and Heredia Nunez, Wilson D and Luckey, Mallory N and Schorr, Emily M and Singh, Anuradha and Tantillo, Gabriela B and Ufongene, Claire and Young, James J and Balchandani, Priti and Festa, Joanne R and Naasan, Georges and Charney, Alexander W and Nadkarni, Girish N and Jetté, Nathalie and Sinai NeuroCOVID-19 Study Group, Sinai NeuroCOVID-19 Study Group},
  title = {Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12370-9}
}
Kostenlos starten →